- Home
- BMEA vs MPV Comparison
BMEA vs MPV Comparison
Compare BMEA & MPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMEA
- MPV
- Stock Information
- Founded
- BMEA 2017
- MPV 1988
- Country
- BMEA United States
- MPV United States
- Employees
- BMEA N/A
- MPV N/A
- Industry
- BMEA Biotechnology: Pharmaceutical Preparations
- MPV Finance Companies
- Sector
- BMEA Health Care
- MPV Finance
- Exchange
- BMEA Nasdaq
- MPV Nasdaq
- Market Cap
- BMEA 153.3M
- MPV 181.3M
- IPO Year
- BMEA 2021
- MPV N/A
- Fundamental
- Price
- BMEA $4.19
- MPV $17.30
- Analyst Decision
- BMEA Buy
- MPV
- Analyst Count
- BMEA 13
- MPV 0
- Target Price
- BMEA $37.25
- MPV N/A
- AVG Volume (30 Days)
- BMEA 1.1M
- MPV 25.2K
- Earning Date
- BMEA 10-29-2024
- MPV 01-01-0001
- Dividend Yield
- BMEA N/A
- MPV 8.71%
- EPS Growth
- BMEA N/A
- MPV N/A
- EPS
- BMEA N/A
- MPV 1.71
- Revenue
- BMEA N/A
- MPV N/A
- Revenue This Year
- BMEA N/A
- MPV N/A
- Revenue Next Year
- BMEA N/A
- MPV N/A
- P/E Ratio
- BMEA N/A
- MPV $9.35
- Revenue Growth
- BMEA N/A
- MPV N/A
- 52 Week Low
- BMEA $3.61
- MPV $11.18
- 52 Week High
- BMEA $20.21
- MPV $16.42
- Technical
- Relative Strength Index (RSI)
- BMEA 24.17
- MPV 62.20
- Support Level
- BMEA $3.81
- MPV $17.05
- Resistance Level
- BMEA $6.06
- MPV $17.22
- Average True Range (ATR)
- BMEA 0.56
- MPV 0.16
- MACD
- BMEA -0.14
- MPV 0.02
- Stochastic Oscillator
- BMEA 7.40
- MPV 88.17
About BMEA Biomea Fusion Inc.
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.
About MPV Barings Participation Investors
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.